MaxCyte Stock

MaxCyte Earnings Yield

The Earnings Yield of MaxCyte (MXCT) as of Aug 6, 2026 is -53.48 %. In the previous year, Earnings Yield was -49.40 % — a change of 8.26% (lower).

Earnings Yield

-53.48 %

YoY

8.26%

Last updated:

Earnings Yield of MaxCyte is 2026 -53.48 % . Earnings Yield of MaxCyte was 2025 -49.40 % . It decreases by 8.26% lower compared to the previous year.
Access this data via the Eulerpool API

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

Earnings Yield of MaxCyte is -53.48 % in 2026.

Earnings Yield of MaxCyte changed from -49.40 % to -53.48 %, representing a 8.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield MaxCyte since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's MaxCyte with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — MaxCyte

All Key Metrics — MaxCyte